Allogene Therapeutics (ALLO) Share-based Compensation (2018 - 2026)
Allogene Therapeutics (ALLO) posted Share-based Compensation of $12.44 million for Q2 2026, up 43.2% from $8.69 million a year earlier and up 50.4% from the prior quarter.
Powered by 
Analysis
Allogene Therapeutics (ALLO) Share-based Compensation (2018 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Share-based Compensation at Allogene Therapeutics was $37.49 million, down 20.4% year-over-year; for FY2025, it was $37.64 million, down 27.3% from FY2024.
- Annual Share-based Compensation has declined for three consecutive years, with a five-year compound annual growth rate of -10.4% (FY2020 to FY2025).
- In prior years, Allogene Therapeutics' Share-based Compensation was $51.74 million in FY2024 (-21.5%), $65.95 million in FY2023 (-21.1%), $83.6 million in FY2022 (+3.4%) and $80.82 million in FY2021 (+23.8%).
- The Q2 2026 figure stands as the highest quarterly Share-based Compensation since Q4 2024.
- On a year-over-year basis, Share-based Compensation increased in two of the last eight quarters, with an average decline of 15.4%.
- The strongest year-over-year quarter for Share-based Compensation in the past five years was Q2 2026, with growth of 43.2%; the weakest was Q4 2025, with a decline of 36.8%.
- According to Business Quant data, Share-based Compensation for the three prior quarters was $8.27 million (Q1 2026), $8.13 million (Q4 2025) and $8.65 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 458.00 Mn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 166.00 Mn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 298.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | - |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 165.00 Mn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 231.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 249.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 170.20 Mn |
| 10 | Allogene Therapeutics | 562.91 Mn | 562.91 Mn | - | 12.44 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 12.44 Mn |
| Mar 31, 2026 | 8.27 Mn |
| Dec 31, 2025 | 8.13 Mn |
| Sep 30, 2025 | 8.65 Mn |
| Jun 30, 2025 | 8.69 Mn |
| Mar 31, 2025 | 12.18 Mn |
| Dec 31, 2024 | 12.87 Mn |
| Sep 30, 2024 | 13.39 Mn |
| Jun 30, 2024 | 13.56 Mn |
| Mar 31, 2024 | 11.92 Mn |
| Dec 31, 2023 | 15.23 Mn |
| Sep 30, 2023 | 15.35 Mn |
| Jun 30, 2023 | 16.59 Mn |
| Mar 31, 2023 | 18.77 Mn |
| Dec 31, 2022 | 17.25 Mn |
| Sep 30, 2022 | 21.15 Mn |
| Jun 30, 2022 | 22.89 Mn |
| Mar 31, 2022 | 22.32 Mn |
| Dec 31, 2021 | 22.04 Mn |
| Sep 30, 2021 | 20.86 Mn |
API Access
Allogene Therapeutics Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=ALLO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "ALLO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=ALLO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();